ApoL1 modulators (Icagen)

N/A

Report date: 2025/03/17 09:42:28
NME

Base Information

Drug NameApoL1 modulators (Icagen)
Drug Alias Nameapolipoprotein L1 modulators (Icagen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein L1 modulators
TargetsApolipoprotein L1
Therapy Area/IndicationsKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesIcagen Inc
Inactive CompaniesN/A
Active IndicationsKidney Failure, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A